Why is JHS Sven.Lab. falling/rising?

As of 15-Sep, JHS Svendgaard Laboratories Ltd is experiencing a decline in its stock price, currently at 11.25, down by 0.45 or 3.85%. The stock has underperformed its sector by 3.86% today and has been on a consecutive downward trend for the last two days, resulting in a total loss of 5.38% during this period. Additionally, the stock has shown significant underperformance over various time frames, with a year-to-date decline of 48.08% and a staggering 62.66% drop over the past year. The company's financial health is concerning, highlighted by a weak long-term fundamental strength, negative EBITDA, and a poor EBIT to Interest ratio of -8.00, which indicates challenges in servicing its debt. Furthermore, the stock's delivery volume has decreased by 20.39% against the 5-day average, suggesting falling investor participation.
In the broader market context, JHS Svendgaard Laboratories Ltd's performance contrasts sharply with the benchmark, as the Sensex has gained 1.24% over the past week and 4.67% year-to-date. This consistent underperformance against the benchmark over the last three years, coupled with a negative return of 62.66% in the past year, reflects a lack of investor confidence. The company's flat results in June and reliance on non-operating income, which constituted 158.73% of profit before tax, further exacerbate concerns about its operational viability. Overall, the combination of weak financial metrics, declining investor interest, and significant underperformance relative to the market contributes to the stock's downward trajectory.